Showing results (851-860 of 7,535) with videos related to

Sort By:
Pageof 754
Molecular Pharmaceutics|June 4, 2011
Liposomal drug formulations in the treatment of rheumatoid arthritisJolanda M van den Hoven, Sophie R Van Tomme, Josbert M Metselaar, et al.
Molecular Pharmaceutics|May 12, 2011
Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal modelAmit K Jain, Nitin K Swarnakar, Manasmita Das, et al.
Molecular Pharmaceutics|June 15, 2011
Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion proteinRuben J Boado, Eric Ka-Wai Hui, Jeff Zhiqiang Lu, et al.
Molecular Pharmaceutics|February 1, 2012
Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunctionXue Xue, Song You, Qiang Zhang, et al.
Molecular Pharmaceutics|February 16, 2012
Enhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injectionXiaohui Zheng, Feifan Zhou, Baoyan Wu, et al.
Molecular Pharmaceutics|February 17, 2012
Insight into the cooperation of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) at the blood-brain barrier: a case study examining sorafenib efflux clearanceSagar Agarwal, William F Elmquist
Molecular Pharmaceutics|January 28, 2012
The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulationsJonathan M Miller, Avital Beig, Robert A Carr, et al.
Molecular Pharmaceutics|February 21, 2012
A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysisSean Ekins, Lei Diao, James E Polli
Molecular Pharmaceutics|January 20, 2012
A new strategy to stabilize oxytocin in aqueous solutions: II. Suppression of cysteine-mediated intermolecular reactions by a combination of divalent metal ions and citrateChristina Avanti, Hjalmar P Permentier, Annie van Dam, et al.
Molecular Pharmaceutics|December 1, 2011
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseasesMeredith A Mintzer, Eric L Dane, George A O'Toole, et al.
Pageof 754